BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19208518)

  • 1. Detection and characterization of hepatocellular carcinoma in rats with liver cirrhosis: diagnostic value of combined use of MR positive and negative contrast agents.
    Guo DM; Qiu TS; Bian J; Liu SF; Wang CZ
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):65-70. PubMed ID: 19208518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of hepatocellular carcinoma (HCC) using super paramagnetic iron oxide (SPIO)-enhanced MRI: Added value of diffusion-weighted imaging (DWI).
    Nishie A; Tajima T; Ishigami K; Ushijima Y; Okamoto D; Hirakawa M; Nishihara Y; Taketomi A; Hatakenaka M; Irie H; Yoshimitsu K; Honda H
    J Magn Reson Imaging; 2010 Feb; 31(2):373-82. PubMed ID: 20099351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypervascular hepatocellular carcinoma in the cirrhotic liver: diffusion-weighted imaging versus superparamagnetic iron oxide-enhanced MRI.
    Chung J; Yu JS; Kim DJ; Chung JJ; Kim JH; Kim KW
    Magn Reson Imaging; 2011 Nov; 29(9):1235-43. PubMed ID: 21907517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal hepatic lesions: detection and characterization with combination gadolinium- and superparamagnetic iron oxide-enhanced MR imaging.
    Kim MJ; Kim JH; Chung JJ; Park MS; Lim JS; Oh YT
    Radiology; 2003 Sep; 228(3):719-26. PubMed ID: 12881583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Superparamagnetic iron oxide-enhanced magnetic resonance imaging of hepatocellular carcinoma in rats].
    Liu X; Xu YK; Huang QL; Wu YK
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1061-5. PubMed ID: 12480574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A computer-aided diagnostic system to discriminate SPIO-enhanced magnetic resonance hepatocellular carcinoma by a neural network classifier.
    Guo D; Qiu T; Bian J; Kang W; Zhang L
    Comput Med Imaging Graph; 2009 Dec; 33(8):588-92. PubMed ID: 19656655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
    Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
    Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of multi-/single-detector row CT and contrast-enhanced MRI in the detection of hepatocellular carcinomas meeting the milan criteria before liver transplantation.
    Kim SH; Choi BI; Lee JY; Kim SJ; So YH; Eun HW; Lee JM; Han JK
    Intervirology; 2008; 51 Suppl 1():52-60. PubMed ID: 18544949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfusion-weighted MRI in evaluating the intranodular hemodynamic characteristics of dysplastic nodules and hepatocellular carcinomas in an experimental rat model.
    Xu H; Xie JX; Li X; Yang ZH; Zheng ZZ; Wang B; Wang Z
    J Magn Reson Imaging; 2008 Jan; 27(1):102-9. PubMed ID: 18022847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis.
    Ward J; Guthrie JA; Scott DJ; Atchley J; Wilson D; Davies MH; Wyatt JI; Robinson PJ
    Radiology; 2000 Jul; 216(1):154-62. PubMed ID: 10887242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superparamagnetic iron oxides and low molecular weight gadolinium chelates are synergistic for direct visualization of advanced liver fibrosis.
    Hughes-Cassidy F; Chavez AD; Schlang A; Hassanein T; Gamst A; Wolfson T; Sirlin C
    J Magn Reson Imaging; 2007 Sep; 26(3):728-37. PubMed ID: 17685418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of gadoxetic acid-enhanced MRI and superparamagnetic iron oxide-enhanced MRI for the detection of hepatocellular carcinoma.
    Kim YK; Kim CS; Han YM; Park G; Hwang SB; Yu HC
    Clin Radiol; 2010 May; 65(5):358-65. PubMed ID: 20380933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers.
    Ma HL; Xu YF; Qi XR; Maitani Y; Nagai T
    Int J Pharm; 2008 Apr; 354(1-2):217-26. PubMed ID: 18191350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver.
    Kim JI; Lee JM; Choi JY; Kim YK; Kim SH; Lee JY; Han JK; Choi BI
    Invest Radiol; 2008 Mar; 43(3):202-10. PubMed ID: 18301317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?
    Goshima S; Kanematsu M; Kondo H; Yokoyama R; Tsuge Y; Shiratori Y; Onozuka M; Moriyama N
    J Magn Reson Imaging; 2008 Apr; 27(4):834-9. PubMed ID: 18383261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3 T MRI of hepatocellular carcinomas in patients with cirrhosis: does T2-weighted imaging provide added value?
    Guo L; Liang C; Yu T; Wang G; Li N; Sun H; Gao F; Liu C
    Clin Radiol; 2012 Apr; 67(4):319-28. PubMed ID: 22099524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.